Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Distress respiratory; Pneumopathy; coma; left hemiplegia; cerebral hypoxemia; bibasal pneumonia; Fever; This is a spontaneous report from a contactable physician from the Agency Regulatory Authority-WEB, regulatory authority number FR-AFSSAPS-PC20210598. A 93 year old male patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 18Feb2021 (Lot Number: EM6950) as single dose for COVID-19 immunization. Medical history included vascular dementia, stroke 2005, marked leukopathy and pulmonary embolism 2016. The patient''s concomitant medications were unspecified. The patient previously had first dose of COMIRNATY for COVID-19 immunization. On 19Feb2021 24 hours after the second injection, the patient experienced fever and bibasal pneumonia. The patient had antibiotic treatment. On 23Feb2021, the patient experienced coma, left hemiplegia, respiratory distress. Per radiological, there was a disappearance of the pneumopathy, persistent coma probably due to cerebral hypoxemia). The patient died on 23Feb2021 due to the events. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: Distress respiratory; Fever; Pneumopathy; bibasal pneumonia; coma; left hemiplegia; cerebral hypoxemia
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166